-
1
At day 182.5, the SGLT2i risk-table count, cumulative NAION events, and cumulative censoring total reconciled to the full cohort of 90,883 patients.
-
2
Censoring included deaths, prespecified competing events, and end of follow-up; the authors found no indication that it was informative regarding treatment.
-
3
In the overlap-weighted cohort, cause-specific treatment HRs were 1.78 (95% CI, 0.90-3.51) during year 1 and 2.93 (95% CI, 1.75-4.91) thereafter, with no significant between-period difference (P = .25
-
4
Scaled Schoenfeld residuals showed no detected temporal trend (χ²₁ = 0.084; P = .77), supporting the reported HR as an effect summary averaged across follow-up.
-
5
The NAION coding algorithm had an approximately 74.5% positive predictive value, and the authors found no evidence of treatment-group differences in misclassification.
